Evidence map›Paper›PMID 35408908›Full record

ArticleInternational journal of molecular sciences2022

IL11 Activates Pancreatic Stellate Cells and Causes Pancreatic Inflammation, Fibrosis and Atrophy in a Mouse Model of Pancreatitis.

Benjamin Ng, Sivakumar Viswanathan, Anissa A Widjaja, Wei-Wen Lim, Shamini G Shekeran, Joyce Wei Ting Goh, Jessie Tan, Fathima Kuthubudeen, Sze Yun Lim, Chen Xie and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. PdgfrαGenes & diseases · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Interleukins: pathophysiological role in acute pancreatitis.Archives of medical science : AMS · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 3 countries.

Benjamin NgNational Heart Research Institute Singapore, National Heart Centre Singapore, Singapore 169609, Singapore.
Sivakumar ViswanathanCardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.ORCID 0000-0002-9263-1656
Anissa A WidjajaCardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.
Wei-Wen LimNational Heart Research Institute Singapore, National Heart Centre Singapore, Singapore 169609, Singapore.ORCID 0000-0003-0311-943X
Shamini G ShekeranCardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.
Joyce Wei Ting GohCardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.ORCID 0000-0001-9313-4195
Jessie TanNational Heart Research Institute Singapore, National Heart Centre Singapore, Singapore 169609, Singapore.
Fathima KuthubudeenCardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.ORCID 0000-0002-2821-5068
Sze Yun LimCardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.
Chen XieNational Heart Research Institute Singapore, National Heart Centre Singapore, Singapore 169609, Singapore.
Sebastian SchaferCardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.
Eleonora AdamiCardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.
Stuart A CookNational Heart Research Institute Singapore, National Heart Centre Singapore, Singapore 169609, Singapore.
National University of Singapore · SGNational Heart Centre Singapore · SG

Funding

National Medical Research Council CIRG14nov021National Medical Research Council MOH-CIRG18nov-0002National Medical Research Council MOH-OFYIRG18nov-0014National Medical Research Council NMRC/OFYIRG/0053/2017National Medical Research Council NMRC OFYIRG21jun-0022National Medical Research Council NMRC/STaR/0029/2017
6 · The paper itself

Abstract

Interleukin-11 (IL11) is important for fibrosis and inflammation, but its role in the pancreas is unclear. In pancreatitis, fibrosis, inflammation and organ dysfunction are associated with pancreatic stellate cell (PSC)-to-myofibroblast transformation. Here, we show that IL11 stimulation of PSCs, which specifically express IL11RA in the pancreas, results in transient STAT3 phosphorylation, sustained ERK activation and PSC activation. In contrast, IL6 stimulation of PSCs caused sustained STAT3 phosphorylation but did not result in ERK activation or PSC transformation. Pancreatitis factors, including TGFβ, CTGF and PDGF, induced IL11 secretion from PSCs and a neutralising IL11RA antibody prevented PSC activation by these stimuli. This revealed an important ERK-dependent role for autocrine IL11 activity in PSCs. In mice, IL11 was increased in the pancreas after pancreatic duct ligation, and in humans, IL11 and IL11RA levels were elevated in chronic pancreatitis. Following pancreatic duct ligation, administration of anti-IL11RA to mice reduced pathologic (ERK, STAT, NF-κB) signalling, pancreatic atrophy, fibrosis and pro-inflammatory cytokine (TNFα, IL6 and IL1β) levels. This is the first description of IL11-mediated activation of PSCs, and the data suggest IL11 as a stromal therapeutic target in pancreatitis.

Indexed as

Interleukin-11Pancreatitis, ChronicAnimalsAtrophyDisease Models, AnimalFibrosisInflammationInterleukin-6MicePancreasPancreatic Stellate CellsInterleukin-11Interleukin-6cytokineERKgp130IL11IL6immunetherapy

Identifiers

PMID35408908
PMCPMC8999048
OpenAlexW4221099803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.